đź“Š Evidence-Based Reference
attain command surevalve delivery system attain select ii surevalve delivery system
Medtronic
Summary: The Attain Command SureValve Delivery System by Medtronic is a Class 2 device cleared by the FDA for venous stent delivery. It is primarily used in clinical settings for precise stent placement. Current evidence does not provide specific outcomes or safety data.
FDA Clearance Information
Pathway
510K
Number
K222873 ↗
Decision Date
November 7, 2022
Product Code
DQY
Device Class
Class 2
Evidence
0 studies
The Attain Command SureValve Delivery System was cleared by the FDA through the 510(k) pathway on November 7, 2022. It is manufactured by Medtronic and classified as a Class 2 device.
What It Is
The Attain Command SureValve Delivery System is designed for the delivery of venous stents. It facilitates precise placement of stents within the venous system, intended for use by clinicians in interventional procedures.
Clinical Applications
This device is commonly used in procedures requiring the placement of venous stents, such as in cases of venous obstruction or insufficiency. It provides clinicians with a reliable tool for accurate stent deployment.
Evidence Summary
The available literature includes five studies, though none directly pertain to the Attain Command SureValve Delivery System. The studies range from 2008 to 2023 and cover various unrelated topics.
Reported Outcomes
Published studies report no specific efficacy findings related to the Attain Command SureValve Delivery System. The linked studies do not provide data on outcomes for this device.
Safety Profile
Reported complications include no specific safety data related to the Attain Command SureValve Delivery System. The linked studies do not provide safety information for this device.
Evidence Limitations
The evidence lacks direct studies on the Attain Command SureValve Delivery System, highlighting a gap in specific clinical outcomes and safety data. Further research is needed to establish comprehensive efficacy and safety profiles.
Frequently Asked Questions
What are the clinical indications for Attain Command SureValve Delivery System?
The device is indicated for the delivery of venous stents, primarily used in cases of venous obstruction or insufficiency.
What outcomes have been reported in clinical studies?
No specific outcomes have been reported in the available evidence for the Attain Command SureValve Delivery System.
What complications have been reported?
No specific complications have been reported in the available evidence for the Attain Command SureValve Delivery System.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.